Voyager Therapeutics Inc. (VYGR) Live Share Price, Invest From India

Voyager Therapeutics Inc. Stock Performance

as on June 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$3.67
Day's Price Range
$3.80
$3.72
1.34%
Downside
2.15%
Upside
52 Week's Low
52 Week's High
$2.83
52-Week Price Range
$5.55
$3.72
23.92%
Downside
49.19%
Upside

Voyager Therapeutics Inc. share price movements today

Previous Close: $3.62
Open: $3.76
Volume: 462.5K
Day's Low - High: $3.67 - $3.80
52 Week Low - High: $2.83 - $5.55

Voyager Therapeutics Inc. Historical Returns

1 Month Return: + 6.9 %
3 Month Return: -0.53 %
1 Year Return: + 22.37 %
3 Year Return: -71.32 %
5 Year Return: -17.15 %

Voyager Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Voyager Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$225.4M

EPS (TTM)

-1.5843

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-119.9M

Revenue (TTM)

36.5M

Profit Margin

0.00%

Return On Equity TTM

-52.26%

Voyager Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Voyager Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Voyager Therapeutics Inc.	BUY	$225.4M	-17.15%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Voyager Therapeutics Inc. Stock including INR - Dollar returns

The Voyager Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Voyager Therapeutics Inc. investment value today

Current value as on today

₹1,32,894

Returns

₹32,894

(+32.89%)

Returns from Voyager Therapeutics Inc. Stock

₹22,368 (+22.37%)

Dollar Impact

₹10,525 (+10.53%)

Analyst Recommendation on Voyager Therapeutics Inc. Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Voyager Therapeutics Inc.. Average target price of $14.89

Voyager Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Voyager Therapeutics Inc..

What analysts predicted

75.02%UPSIDE

Target Price

$14.89

Current Price

$3.72

Analyzed by

16 Analysts

Target

$14.89

Voyager Therapeutics Inc. target price $14.89, a slight upside of 75.02% compared to current price of $3.72. According to 16 analysts rating.

Indian Investors' Interest in Voyager Therapeutics Inc. Stock

Search interest for Voyager Therapeutics Inc. Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 21, 2026 to June 20, 2026

Change:43% versus previous 30 day period

Voyager Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	90	19	29	24	6	6	5	13	15	2
Gross Profit	88	18	-2	-5	-26	-25	-26	-22	15	1
Operating Income	54	-16	-15	-13	-38	-34	-36	-30	-29	-30
EBITDA	58	-10	-11	-7	-32	-29	-32	-26	-26	-26
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	1	1	1	1	1	1	1	0	1	0
Income Before Tax	57	-11	-10	-9	-33	-30	-33	-27	-27	-27
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	56	-11	-10	-9	-34	-31	-33	-27	-27	-27
Net Profit Margin	62.62%	-58.05%	-34.29%	-36.72%	-549.33%	-479.24%	-641.96%	-208.69%	-178.83%	-1077.40%

Voyager Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	14	10	7	104	171	37	40	250	80	40
Gross Profit	14	10	7	104	62	37	40	157	80	40
Operating Income	-41	-71	-91	-51	27	-73	-50	122	-83	-131
EBITDA	-40	-70	-88	-48	31	-68	-44	138	-59	-115
Interest Expense	0	-	-	-	-	0	1	-	-	-
Depreciation	-	1	2	2	3	5	6	4	4	4
Income Before Tax	-40	-70	-88	-43	36	-71	-46	133	-64	-119
Income Tax Expense	0	-1	0	-2	-1	-5	0	1	0	0
Net Income	-40	-70	-88	-40	36	-66	-46	132	-65	-119
Net Profit Margin	-282.65%	-697.56%	-1158.79%	-39.11%	21.47%	-176.49%	-113.45%	52.93%	-81.25%	-296.53%

Voyager Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-11	-10	-9	-34	-31	-33	-27	-27	-27
Operating Cash Flow	58	-31	-27	-14	-37	-33	-31	-30	-33
Investing Cash Flow	-96	-35	64	-27	41	1	34	47	8
Financing Cash Flow	112	0	0	0	0	0	0	0	3
Change in Cash	75	-66	36	-41	3	-30	1	17	-21

Voyager Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-70	-88	-43	36	-71	-46	132	-65	-119
Operating Cash Flow	-61	-15	48	-96	-53	-12	77	-15	-132
Investing Cash Flow	-3	26	-90	112	65	-7	-141	-94	125
Financing Cash Flow	59	4	80	3	0	1	33	114	0
Change in Cash	-5	15	39	18	12	-18	-30	3	-6

Global Institutional Holdings in Voyager Therapeutics Inc.

Funds	Holdings
BlackRock Inc	9.22%
UBS Group AG	0.79%
Armistice Capital, LLC	5.79%
Royal Bank of Canada	0.52%
Bank of America Corp	0.72%

See all

Insights on Voyager Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, VYGR has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 7 days, VYGR stock has moved up by 6.3%
NO EFFECT
Against Peers
In the last 3 years, Voyager Therapeutics, Inc. Common Stock has experienced a drawdown of -73.4%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 51.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -27.42M → -27.93M (in $), with an average decrease of 1.9% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 15.33M → 2.59M (in $), with an average decrease of 83.1% per quarter

About Voyager Therapeutics Inc.

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.

Organisation	Voyager Therapeutics Inc.
Headquarters	75 Hayden Avenue, Lexington, MA, United States, 02421
Industry	Biotechnology
CEO	Dr. Alfred W. Sandrock Jr., M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Voyager Therapeutics Inc.

Name	Title
Dr. Mark A. Kay M.D., Ph.D.	Founder
Ms. Amy Quinlan	Principal Accounting Officer
Mihalis Kariolis	Vice President of Non-Viral Therapeutics
Mr. Todd Carter Ph.D.	Chief Scientific Officer
Mr. Gregory Shiferman	Senior VP, General Counsel & Secretary
Ms. Trista Morrison	Chief Corporate Affairs Officer & Chief of Staff to the CEO
Dr. Mathieu Nonnenmacher Ph.D.	Vice President of Gene Therapy
Dr. Alfred W. Sandrock Jr., M.D., Ph.D.	President, CEO & Director
Ms. Robin Swartz	Principal Financial Officer, Treasurer, Chief Business Officer & COO
Dr. Krystof Bankiewicz M.D., Ph.D.	Founder

FAQs

What is Voyager Therapeutics Inc. share price today?

Voyager Therapeutics Inc. share price today is $3.72 as on June 19, 2026 at 8:45 am IST at the close of the market. Voyager Therapeutics Inc. share today touched a day high of $3.8 and a low of $3.67.

What is the 52 week high and 52 week low for Voyager Therapeutics Inc. share?

Voyager Therapeutics Inc. share touched a 52 week high of $5.55 on October 16, 2025 and a 52 week low of $2.83 on June 27, 2025. Voyager Therapeutics Inc. stock price today i.e. June 19, 2026 at 8:45 am IST is closed at $3.72,which is 32.97% down from its 52 week high and 31.45% up from its 52 week low.

What is Voyager Therapeutics Inc.'s market capitalisation today?

Voyager Therapeutics Inc. market capitalisation is $0.00T as on June 19, 2026 at 8:45 am IST.

How to invest in Voyager Therapeutics Inc. Stock (VYGR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Voyager Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Voyager Therapeutics Inc. Shares that will get you 0.4032 shares as per Voyager Therapeutics Inc. share price of $3.72 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Voyager Therapeutics Inc. Stock (VYGR) from India?

Indian investors can start investing in Voyager Therapeutics Inc. (VYGR) shares with as little as ₹94.31 or $1 (as of June 20, 2026 at 8:58 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Voyager Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 20, 2026 at 8:58 pm IST). Based on Voyager Therapeutics Inc. share’s latest price of $3.72 as on June 19, 2026 at 8:45 am IST, you will get 2.6882 shares of Voyager Therapeutics Inc.. Learn more about fractional shares .

What are the returns that Voyager Therapeutics Inc. has given to Indian investors in the last 5 years?

Voyager Therapeutics Inc. stock has given -17.15% share price returns and 27.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?